Pulmonx Corporation LUNG United States — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's united states — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulmonx Corporation's united states — revenue?
- Pulmonx Corporation (LUNG) reported united states — revenue of $13.26M in Q1 2026.
- How has Pulmonx Corporation's united states — revenue changed year-over-year?
- Pulmonx Corporation's united states — revenue decreased by 6.8% year-over-year, from $14.22M to $13.26M.
- What is the long-term trend for Pulmonx Corporation's united states — revenue?
- Over 4 years (2021 to 2025), Pulmonx Corporation's united states — revenue has grown at a 22.9% compound annual growth rate (CAGR), from $24.99M to $57.02M.
- What does united states — revenue mean?
- This metric represents the total gross sales generated from products and services sold within the United States geographic market. It serves as a primary indicator of the company's commercial penetration, market adoption, and sales performance in its largest domestic region. Tracking this figure helps investors assess the effectiveness of regional sales strategies and the growth trajectory of the core business in the U.S. healthcare sector.